Diversified Corporate Resources Announces Two Million Dollar Plus Pace in Emerging `Nuclear Pharmacy' Market Niche for 2004.

Business Editors

DALLAS--(BUSINESS WIRE)--March 18, 2004

Diversified Corporate Resources Inc. (AMEX:HIR) announced that a new market niche, nuclear pharmacy, is tracking at a rate of twice the original projected revenue.

Ron Vallely, CPC and President of the DCRI/MAGIC Perm/Direct placement division, was delighted with the latest statistics. "We have entered new and exciting areas within the Biopharm arena. This is a direct result of detailed research coupled with hard work. We expect to exceed 2 million dollars (in revenue) for 2004 in this one niche area alone. Not only does the potential for growth excite us, but given the highly specialized skill set of these individuals, the margins are very attractive."

Nuclear Pharmacy is a branch of pharmacy that develops and studies diagnostic and therapeutic radioactive compounds. The discipline concerns the preparation, dispensing and monitoring of radioactive drugs that are designed to detect and treat certain diseases in people.

Shannon Thomas, MAGIC's director for this niche market, has over 1,000 job openings. "We have been dealing directly with hospitals in this segment. To date, we have been very successful in filling orders for both permanent and contract job openings."

Diversified Corporate Resources Inc. is an employment services firm that recruits and places engineering, biotech and healthcare, information technology, technical and other professional personnel on a contract and direct basis to high-end specialty employment markets. The Company currently operates a nationwide network of eight offices to support its Fortune 500 client companies and others.

Additional information regarding Diversified Corporate Resources can be found on the Company's Web site at www.dcri.net.

Statements in this Press Release that are not historical facts, including, but not limited to, projections or expectations of future financial or economic performance of the Company, and statements of our plans and objectives for future operations are "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and involve a number of risks and uncertainties. No assurance can be given that actual results or events will not differ materially from those projected, estimated, assumed or anticipated in any such "forward-looking" statements. Important factors (the "Cautionary Disclosures") that could result in such differences include: general economic conditions in our markets, including inflation, recession, interest rates and other economic factors; the availability of qualified personnel; our ability to successfully integrate acquisitions or joint ventures with our operations (including the ability to successfully integrate businesses that may be diverse as to their type, geographic area or customer base); the level of competition experienced by us; our ability to implement our business strategies and to manage our growth; the level of development revenues and expenses; the level of litigation expenses; our ability to effectively implement an e-commerce strategy; and other factors that affect businesses generally. Subsequent written and oral "forward-looking" statements attributable to us, or persons acting on our behalf, are expressly qualified by the Cautionary Disclosures.